Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients

  1. Roldán, V.
  2. Marín, F.
  3. Muiña, B.
  4. Torregrosa, J.M.
  5. Hernández-Romero, D.
  6. Valdés, M.
  7. Vicente, V.
  8. Lip, G.Y.H.
Revue:
Journal of the American College of Cardiology

ISSN: 0735-1097,  1558-3597

Année de publication: 2011

Volumen: 57

Número: 25

Pages: 2496-2504

Type: Article

DOI: 10.1016/J.JACC.2010.12.033 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus